|
| |
| 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol IUPAC name | |
| CAS number 26864-56-2 |
ATC code |
| PubChem 33630 |
DrugBank [1] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 523.965 |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
Penfluridol is a piperidine antipsychotic. It was discovered at Janssen Pharmaceutica in 1968.
References[]
- Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, Van Nueten JM, Schaper WK., The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug, Eur J Pharmacol. 1970 Jul 15;11(2):139-54.
- van Praag HM, Schut T, Dols L, van Schilfgaarden R., Controlled trial of penfluridol in acute psychosis,
Br Med J. 1971 Dec 18;4(5789):710-3.